Defensins, a family of 3-4 KD cationic peptides, have been found recently in the cytoplasmicgranules of human, rabbit, guinea pig and rat polymorphonuclear neutrophils and rabbit alveolarmacrophages. The defence roles of these molecules, such as antimicrobial activity, viral inactiva-tion, tumor cell cytotoxicity, chemotactic and opsonic actions, etc. have been adequately studied.In order to investgate the role of Defensins in the neutrphil-mediated pathological process ofsome diseases, we isolated and purified human neutrophil Defensins. By using Sephadex G100and Bio-gel P10 gel filtration chromatography, the purified molecules were obtained. The puritywas identified by AU-PAGE,SDS-PAGE, and amino acid composition analysis. In vitro fugicidalactivity of the purified human neutrophil Defensins against Candida albicans was also examined.When incubated with 33 Mol concentration of human Defensins, more than 90% of Candida,al-bicans were killed in the methylene blue assay system.

Notch signal pathway is closely related to the organism's development and a variety of cancers. Current models available for screening modulators of Notch signal pathway all use mouse Notch protein as substrates and those models which use human Notch protein have not been reported. To make the screen results much more reliable, the authors cloned a truncated form of human Notch1 called N100, and built the screening models for the use of it instead of mouse Notch protein. The models included an in vitro screening model based on the purified gamma-secretase enzyme and a cell model using luciferase reporter system. The screening models then have been verified by the known modulators of Notch signal pathway and the IC50 values have been obtained. The verified models can be used to screen modulators of human Notch signaling pathway effectively and it can lay the foundation for finding new modulators of this kind effectively.
Amyloid Precursor Protein Secretases ; Animals ; Drug Evaluation, Preclinical ; methods ; Humans ; Luciferases ; Mice ; Receptors, Notch ; antagonists & inhibitors ; Signal Transduction

Antirheumatic Agents ; therapeutic use ; Arthritis, Rheumatoid ; drug therapy ; Drug Therapy, Combination ; Drugs, Chinese Herbal ; therapeutic use ; Etanercept ; Female ; Humans ; Immunoglobulin G ; therapeutic use ; Male ; Methotrexate ; therapeutic use ; Phytotherapy ; Prednisone ; therapeutic use ; Receptors, Tumor Necrosis Factor ; therapeutic use

Objective To explore effect of clinical pathway in turnout gene therapy's health education,to promote turnout sufferer's acknowledge of gene therapy,thus to better cooperate the treatment.Methods To apply the clinical pathway to the in-patient health education,to explain and evaluate to the turnout gene therapy's sufferer.Resuits The sufferers'acknowledge of tumour gene therapy promoted and their cognition of the therapy's side effect promoted,so they can better regard gene therapy.Simultaneously the relationship of nurse-sufferer improve and the nurse's ability of health education improved.Conclusion Clinical pathway has good using value in the health educadon of promoting turnout gene therapy's sufferer's acknowledge.

Objective To investigate the efficacy and safety of trastuzumab combined with docetaxel chemotherapy in the treatment of stage Ⅲ breast cancer.Methods 150 cases of stage Ⅲ breast cancer patients from October 2013 to September 2015 in our hospital were selected and randomly divided into experimental group and control group,75 cases in each group,the control group were treated with cyclophosphamide and doxorubicin treatment,experimental group were treated with trastuzumab combined with docetaxel chemotherapy.To 21 days for a course of treatment,all patients were treated three courses.The levels of serum C reactive protein(C-reactive protein,CRP),the total effective rate and the incidence of adverse reactions in two groups before and after treatment were compared.Results After treatment,the level of serum CRP in the two groups decreased significantly,the difference was statistically significant(P<0.05),the CRP levels of serum in experimental group was significantly lower than the control group,the difference was statistically significant(P<0.05),the clinical total effective rate is higher,the difference was statistically significant(P<0.05),the incidence rate of adverse reaction was lower,the difference was statistically significant(P<0.05).Conclusion Trastuzumab combined with docetaxel chemotherapy can effectively reduce the inflammatory response in patients with stage Ⅲ breast cancer,improve clinical efficacy,and effectively reduce the adverse reactions of patients.

The status quo and application of acupuncture therapy in Oman is introduced in this article. The gene -ral medical condition of Oman is comparatively backward. Function of local traditional medicine is limited. Indications of acupuncture in Oman are various pain syndromes and motor impairment after stroke. However, it is lack of systematic training and management of acupuncture practitioners. And the number of acupuncture clinic is comparatively inadequate. Therefore, qualified acupuncture training, publicity and cooperation with international organizations are highly recommended in the future.
Acupuncture Therapy ; trends ; Humans ; Oman

Objective: To investigate the clinical effect and follow-up outcome of the intracranial stent overlapping technique in the treatment of unruptured vertebrobasilar dissecting aneurysms (VBDAs). Methods: Ten patients with VBDAs had 12 unruptured VBDAs were analyzed retrospectively. The patients were treated using intracranial stent overlapping technique and LEO stents (9 patients using 2 stents, 1 using 3 stents). The aneurysms were occluded by changing the hemodynamics of the aneurysmal cavities, and the parent arteries were preserved. All the patients completed clinical and imaging follow-up study. Results: Circled digit oneOf the 10 patients with VBDAs, 7 had headache, 1 had ataxia, 3 had dizziness, and 1 had facial numbness. Image examination revealed proximal segment stenosis, string and pearl sign, wave shaped, double-lumen sign, and intramural hematoma, respectively. Circled digit twoAngiography revealed contrast agent retention in the aneurysm cavity immediately after stenting. Stent migration occurred in 1 patient, but it did not result neurological dysfunction. Two patients had transient ischemia attack after stenting, it was relieved after symptomatic treatment. The remaining patients did not have any nervous system complications. Head CT scan before discharge did not revealed any new brain infarctions. Circled digit twoAngiographic examination showed that 6 dissecting aneurysms were occluded completely at 6 months after stenting and the other 6 ones were occluded partially. The patients were followed up for 8 to 27 months, and the final mRS score was 0 in 10 patients. There were no technique-related complications in the patients during the follow-up period. Conclusion: Intracranial stent overlaping technique in the treatment of unruptured VBDAs is safe and effective.

Objective: To investigate the clinical effect of liquid embolic agent Onyx in the treatment of peripheral intracranial aneurysms. Methods: Nine patients with 10 peripheral intracranial aneurysms were studied prospectively. Five aneurysms were in the distal posterior inferior cerebellar artery, two in the distal superior cerebellar artery, one in the distal posterior cerebral artery, and two in the distal middle cerebral artery. All patients were treated with Onyx to occlude their proximal parent arteries and aneurysms. They were followed up for 6 to 31 months. Results: The aneurysms were occluded completely in all the patients. Seven patients had a good recovery, and the Glasgow outcome scale (GOS) score was 5. One patient had left extremity paralysis before the procedure and it did not have any change alter the procedure (GOS 3); one patient died. Head CT scan was performed before discharge, only one patient showed left parietal lobe infarction, but he did not have obvious symptoms. Four patients were reexamined by DSA at 6 months after the procedure, and the aneurysms did not recurred. Four patients were followed-up clinically. No new neurological dysfunction and rebleeding were observed in all the patients. Conclusion: Onyx occlusion of aneurysms and its proximal parent arteries for treatment of peripheral intracranial artery aneurysms is safe and effective. Further clinical and imaging follow-up are needed for long-term result.

Objective: To examine the expression and promoter CpG island methylation of glutathione S-transferase M3 (GSTM3) gene in clear cell renal cell carcinoma (ccRCC), and to evaluate the relationship of expression, methylation of GSTM3 gene with the metastasis and oncogenesis of ccRCC. Methods: Using semi-quantitative RT-PCR technique, we examined GSTM3 expression in surgical specimens of 24 primary ccRCCs and adjacent non-malignant tissues, 14 metastatic ccRCCs and 2 ccRCC cell lines (RCC05-TXJ,RCC05-ZTJ) with different metastatic potentials. RCC05-TXJ cells were cultured in RPMI 1640 medium and treated with DNA methyltransferase inhibitor 5-aza-2′-deoxycytidine (5-Aza-CdR). Semi-quantitative RT-PCR was used to examine the expression of GSTM3 in response to 5-Aza-CdR treatment. Nested bisulfite sequencing PCR and DNA sequencing were used to analyze different methylation locuses in GSTM3 gene promoter in 10 primary ccRCCs and adjacent non-malignant tissues. We also examined the methylation level in 10 primary ccRCCs and the corresponding non-malignant tissues as well as 8 metastatic tissues by nested methylation-specific PCR. Results: Expression of GSTM3 gene in metastatic ccRCC cells (RCC05-TXJ) was lower than that in the non-metastatic ccRCC cells (RCC05-ZYJ). Down-regulation of GSTM3 gene expression was found in 17 of the 24 primary ccRCCs as compared with the non-malignant tissue. Expression of GSTM3 in the metastatic ccRCCs was lower than that in primary ccRCCs. 5-Aza-CdR treatment increased GSTM3 expression in RCC05-ZYJ. Methylation in GSTM3 promoter was found in 4 of 10 ccRCC tissues, 2 of 10 adjacent tissues, and 1 of 8 metastatic tissues. No significant difference was found between ccRCC and adjacent tissues (P = 0.628) or ccRCC and metastatic disease (P = 0.314) due to limit number of cases. Conclusion: Our findings support that promoter aberrant methylation is one of the major mechanisms of GSTM3 gene down-regulation in ccRCC. The preliminary identification of GSTM3 promoter methylation sites may provide a basis for further study.

Intestinal microflora is a general term for microbial communities that reside in the human intestine. In recent years, the research on diseases related to intestinal microbiota has developed rapidly. It is found that intestinal microbiota is closely related to digestive tract diseases, metabolic diseases, immune diseases, mental diseases, and lung diseases. Intestinal dysbacteriosis, mucosal barrier damaging and local immune dysfunction may be involved in a variety of disease processes. In addition, respiratory diseases such as asthma and pneumonia seriously affect human health. The intestinal microbiota is crucial in regulating immune response of lung to pathological mechanism of diseases including asthma, pneumonia and pulmonary tuberculosis. Therefore, it may be a new direction for the treatment of lung diseases by understanding intestinal microbiota in lung diseases, and identifying, describing and manipulating immunity network of pulmonary disease.